A filter paper method for determining isoniazid acetylator phenotype.
作者信息
Weber W W, Brenner W
出版信息
Am J Hum Genet. 1974 Jul;26(4):467-73.
Abstract
摘要
相似文献
1
A filter paper method for determining isoniazid acetylator phenotype.一种用于确定异烟肼乙酰化酶表型的滤纸法。
Am J Hum Genet. 1974 Jul;26(4):467-73.
2
Acetylator phenotypes in Papua New Guinea.巴布亚新几内亚的乙酰化表型。
J Med Genet. 1983 Feb;20(1):37-40. doi: 10.1136/jmg.20.1.37.
3
Acetylator phenotyping with sulphadimidine in patients receiving isoniazid.接受异烟肼治疗的患者中使用磺胺二甲嘧啶进行乙酰化表型分析。
Int J Clin Pharmacol Res. 1984;4(2):141-4.
4
Catalytic properties and heat stabilities of novel recombinant human N-acetyltransferase 2 allozymes support existence of genetic heterogeneity within the slow acetylator phenotype.新型重组人N-乙酰转移酶2同工酶的催化特性和热稳定性支持慢乙酰化表型内存在基因异质性。
Arch Toxicol. 2017 Aug;91(8):2827-2835. doi: 10.1007/s00204-017-1989-7. Epub 2017 May 18.
5
An enzyme marker to ensure reliable determinations of human isoniazid acetylator phenotype in vitro.
Pharmacology. 1981;23(4):203-10. doi: 10.1159/000137551.
6
The incidence of the acetylator phenotype of isoniazid in healthy and in pulmonary tuberculosis subjects in Bihar.比哈尔邦健康人群及肺结核患者中异烟肼乙酰化表型的发生率。
J Assoc Physicians India. 1978 May;26(5):353-60.
7
Determination of the acetylator phenotype using matrix isoniazid.使用基质异烟肼测定乙酰化表型。
Tubercle. 1975 Sep;56(3):203-9. doi: 10.1016/0041-3879(75)90053-7.
8
9
[Study of the acetylator phenotype in Andalusia].[安达卢西亚乙酰化表型研究]
Rev Clin Esp. 1985 Jun;177(2):75-7.
10
The determination of the acetylator phenotype of tuberculosis patients in Czechoslovakia using sulphadimidine.
Tubercle. 1973 Mar;54(1):67-71. doi: 10.1016/0041-3879(73)90016-0.
引用本文的文献
1
Characterization of human lymphocyte N-acetyltransferase and its relationship to the isoniazid acetylator polymorphism.人类淋巴细胞N-乙酰基转移酶的特性及其与异烟肼乙酰化多态性的关系。
Biochem Genet. 1980 Oct;18(9-10):889-904. doi: 10.1007/BF00500122.
2
Isoniazid disposition, comparison of isoniazid phenotyping methods in and acetylator distribution of Japanese patients with idiopathic systemic lupus erythematosus and control subjects.异烟肼代谢、日本特发性系统性红斑狼疮患者与对照受试者的异烟肼表型分析方法比较及乙酰化酶分布
Br J Clin Pharmacol. 1982 Mar;13(3):361-74. doi: 10.1111/j.1365-2125.1982.tb01387.x.
3
A simple test for acetylator phenotype using caffeine.一种使用咖啡因检测乙酰化酶表型的简单测试。
Br J Clin Pharmacol. 1984 Apr;17(4):459-64. doi: 10.1111/j.1365-2125.1984.tb02372.x.
4
The association of the slow acetylator phenotype with bladder cancer.慢乙酰化酶表型与膀胱癌的关联。
J Med Genet. 1983 Oct;20(5):330-3. doi: 10.1136/jmg.20.5.330.
5
Survey of the human acetylator polymorphism in spontaneous disorders.自发性疾病中人类乙酰化多态性的调查。
J Med Genet. 1984 Aug;21(4):243-53. doi: 10.1136/jmg.21.4.243.
6
Path analysis in genetic epidemiology: a critique.遗传流行病学中的路径分析：一项批判性分析。
Am J Hum Genet. 1983 Jul;35(4):695-732.
7
Glucose-6-phosphate dehydrogenase deficiency and sulfadimidin acetylation phenotypes in Egyptian oases.
Biochem Genet. 1992 Apr;30(3-4):113-21. doi: 10.1007/BF02399702.
8
N-acetyltransferase phenotype and risk in urinary bladder cancer: approaches in molecular epidemiology. Preliminary results in Sweden and Denmark.N-乙酰转移酶表型与膀胱癌风险：分子流行病学方法。瑞典和丹麦的初步结果。
Environ Health Perspect. 1979 Apr;29:71-9. doi: 10.1289/ehp.792971.
9
Clinical pharmacokinetics of isoniazid.异烟肼的临床药代动力学
Clin Pharmacokinet. 1979 Nov-Dec;4(6):401-22. doi: 10.2165/00003088-197904060-00001.
10
Aromatic amino acetylation in the adult and neonatal marmoset [proceedings].成年和新生狨猴中的芳香族氨基酸乙酰化[会议论文集]
Br J Pharmacol. 1979 Jul;66(3):419-421P. doi: 10.1111/j.1476-5381.1979.tb10847.x.
本文引用的文献
1
Studies of human patterns of isoniazid metabolism using an intravenous fall-off technique with a chemical method.采用静脉滴注技术结合化学方法对异烟肼人体代谢模式进行的研究。
Am Rev Respir Dis. 1960 Jan;81:1-8. doi: 10.1164/arrd.1960.81.1.1.
2
Genetic control of isoniazid metabolism in man.人体中异烟肼代谢的遗传控制。
Br Med J. 1960 Aug 13;2(5197):485-91. doi: 10.1136/bmj.2.5197.485.
3
The discrimination of phenotypes for rate of disappearance of isonicotinoyl hydrazide from serum.血清中异烟酰肼消失速率的表型鉴别
J Clin Invest. 1969 Jul;48(7):1173-6. doi: 10.1172/JCI106081.
4
The rate of isoniazid inactivation in Finnish diabetic and non-diabetic patients.
Ann Med Exp Biol Fenn. 1967;45(4):423-7.
5
Sulphadimidine acetylation test for classification of patients as slow or rapid inactivators of isoniazid.用于将患者分类为异烟肼慢灭活者或快灭活者的磺胺二甲嘧啶乙酰化试验。
Br Med J. 1970 Aug 29;3(5721):495-7. doi: 10.1136/bmj.3.5721.495.
6
Human variability in the metabolism of sulfamethazine.磺胺二甲嘧啶代谢中的个体差异。
Hum Hered. 1969;19(4):402-9. doi: 10.1159/000152245.
7
An improved and simplified method of detecting the acetylator phenotype.一种检测乙酰化酶表型的改良简化方法。
J Med Genet. 1969 Dec;6(4):405-7. doi: 10.1136/jmg.6.4.405.
8
Inactivation of isoniazid by Canadian Eskimos and Indians.加拿大爱斯基摩人和印第安人对异烟肼的灭活作用。
Can Med Assoc J. 1972 Feb 19;106(4):331-5.
9
The polymorphic acetylation of sulphapyridine in man.人磺胺吡啶的多态性乙酰化作用。
J Med Genet. 1972 Jun;9(2):168-71. doi: 10.1136/jmg.9.2.168.
10
The use of the autoanalyzer to determine the acetylator phenotype.使用自动分析仪来确定乙酰化酶表型。
J Med Genet. 1972 Mar;9(1):57-9. doi: 10.1136/jmg.9.1.57.
Zotero 插件